Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas
Sponsor: Ohio State University Comprehensive Cancer Center
Summary
This trial studies how well 68Ga-DOTATATE digital PET/CT work in diagnosing soft tissue sarcoma. 68Ga-DOTATATE is a radiotracer that may improve image quality of PET imaging. PET is an established imaging technique that utilizes small amounts of radioactivity attached to very minimal amounts of tracer, in the case of this research, 68Ga-DOTATATE. CT images provide an exact outline of organs and potential inflammatory tissue where it occurs in patient's body. 68Ga-DOTATATE digital PET/CT may work better in imaging patients with soft tissue sarcomas.
Official title: Clinical Feasibility and Potential Clinical Benefit of 68Ga-DOTATATE PET/CT Assessment of Soft Tissue Sarcomas for Potential Peptide Receptor Radionuclide Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-09-30
Completion Date
2026-12-31
Last Updated
2026-02-02
Healthy Volunteers
No
Conditions
Interventions
Computed Tomography
Undergo dPET/CT
Gallium Ga 68-HA-DOTA-TATE
Given IV
Positron Emission Tomography
Undergo dPET/CT
Locations (1)
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States